We are live on ! Find out more
IAM

Innovis Asset Management Portfolio holdings

AUM $260M
1-Year Est. Return 28.13%
This Fund
S&P 500
This Quarter Est. Return
+10.77%
1 Year Est. Return
+28.13%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$271M
AUM Growth
+$24.2M
Cap. Flow
+$3.94M
Cap. Flow %
1.45%
Top 10 Hldgs %
35%
Holding
186
New
25
Increased
37
Reduced
82
Closed
24

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$4.52M
2
ROK icon
Rockwell Automation
ROK
+$4.16M
3
NEM icon
Newmont
NEM
+$3.45M
4
EMR icon
Emerson Electric
EMR
+$3.41M
5
MSFT icon
Microsoft
MSFT
+$2.94M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$5.32M
2
FCX icon
Freeport-McMoran
FCX
+$3.32M
3
CTVA icon
Corteva
CTVA
+$3.26M
4
DVN icon
Devon Energy
DVN
+$3.24M
5
UNH icon
UnitedHealth
UNH
+$2.68M

Sector Composition

Rank Sector Weight
1 Technology 31.6%
2 Healthcare 22.77%
3 Financials 8.72%
4 Energy 6.58%
5 Consumer Staples 6.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XOM icon
26
ExxonMobil
XOM
$642B
$4.37M 1.61%
40,749
-22
-0.1% -$2.4K
ON icon
27
ON Semiconductor
ON
$18.6B
$4.32M 1.6%
45,671
-9
-0% -$744
SBUX icon
28
Starbucks
SBUX
$120B
$4.25M 1.57%
42,861
+604
+1% +$62.7K
ALB icon
29
Albemarle
ALB
$14.8B
$3.44M 1.27%
15,435
+4,465
+41% +$913K
AMZN icon
30
Amazon
AMZN
$2.94T
$3.3M 1.22%
25,306
-206
-0.8% -$23.5K
PFGC icon
31
Performance Food Group
PFGC
$18B
$3.22M 1.19%
53,432
-605
-1% -$35.6K
KO icon
32
Coca-Cola
KO
$374B
$2.59M 0.96%
43,074
-9
-0% -$560
QQQ icon
33
Invesco QQQ Trust
QQQ
$479B
$2.3M 0.85%
6,215
-225
-3% -$75.7K
SEDG icon
34
SolarEdge
SEDG
$1.99B
$2.15M 0.79%
7,993
+208
+3% +$59.6K
ILMN icon
35
Illumina
ILMN
$29.3B
$1.9M 0.7%
10,444
-21
-0.2% -$4.25K
GE icon
36
GE Aerospace
GE
$389B
$1.88M 0.69%
21,435
PYPL icon
37
PayPal
PYPL
$51.1B
$1.68M 0.62%
25,227
+228
+0.9% +$15.5K
ABBV icon
38
AbbVie
ABBV
$431B
$1.59M 0.59%
11,793
-97
-0.8% -$14.2K
IXC icon
39
iShares Global Energy ETF
IXC
$2.78B
$1.58M 0.59%
42,568
-329
-0.8% -$12.4K
JNJ icon
40
Johnson & Johnson
JNJ
$619B
$1.34M 0.49%
8,074
-73
-0.9% -$11.8K
AVGO icon
41
Broadcom
AVGO
$2T
$1.3M 0.48%
14,940
-3,630
-20% -$259K
JPM icon
42
JPMorgan Chase
JPM
$947B
$1.29M 0.48%
8,885
-27
-0.3% -$3.71K
REGN icon
43
Regeneron Pharmaceuticals
REGN
$79.5B
$1.17M 0.43%
1,628
-15
-0.9% -$11.6K
CME icon
44
CME Group
CME
$95B
$1.07M 0.4%
5,797
-184
-3% -$34K
SPY icon
45
State Street SPDR S&P 500 ETF Trust
SPY
$818B
$1.05M 0.39%
2,374
-132
-5% -$55.4K
IBM icon
46
IBM
IBM
$220B
$1.05M 0.39%
7,832
+825
+12% +$106K
IJR icon
47
iShares Core S&P Small-Cap ETF
IJR
$111B
$1.01M 0.37%
10,136
-558
-5% -$53.1K
EEM icon
48
iShares MSCI Emerging Markets ETF
EEM
$29.2B
$979K 0.36%
24,750
CSCO icon
49
Cisco
CSCO
$476B
$937K 0.35%
18,113
-96
-0.5% -$4.72K
META icon
50
Meta Platforms (Facebook)
META
$1.5T
$921K 0.34%
3,210

Similar funds

Innovis Asset Management's Q2 2023 Portfolio in Review

As of Q2 2023, Innovis Asset Management held 186 positions worth $271M, up 9.8% from $247M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Innovis Asset Management's Q2 2023 filing shows 25 new, 37 increased, 82 reduced and 24 closed positions. Its largest new stake was DexCom: 37,345 shares worth $4.8M. The largest sale was Pfizer, an estimated $5.32M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.

  • Innovis Asset Management's largest Q2 2023 buy was DexCom: 37,345 shares worth $4.8M.
  • Innovis Asset Management added most to Newmont in Q2 2023, an estimated $3.45M increase.
  • Innovis Asset Management's biggest Q2 2023 reduction was Pfizer, cutting an estimated $5.32M.
  • Innovis Asset Management fully exited Freeport-McMoran in Q2 2023, selling an estimated $3.32M.
  • Innovis Asset Management's ten largest holdings make up 35% of its $271M portfolio in Q2 2023.
  • Innovis Asset Management opened 25 new positions and closed 24 in Q2 2023.
  • Innovis Asset Management's portfolio value rose 9.8% quarter-over-quarter to $271M.

Based on Innovis Asset Management's 13F filing for Q2 2023, filed 3 Aug 2023.